Valeo Pharma Inc

Rooted in specialty pharma, Valeo is growing Canadian healthcare by licensing and acquiring Canadian rights to commercial stage, innovative, and proprietary drugs. 

Founded in 2003, Valeo Pharma originally focused on dermatology and Hospital specialty, until 2014 when it sold its entire product portfolio to Valeant ($27M).

Management and a growing base of employees (100+) is now refocused on large new therapeutic areas and commercializing drugs in Canada.